Medicine & Life Sciences
tolfenamic acid
100%
Neoplasms
91%
Pancreatic Neoplasms
87%
Methane
54%
Sp Transcription Factors
54%
Liver Transplantation
50%
Growth
48%
Transplants
47%
Medical Oncology
42%
Cholangiocarcinoma
41%
Immunotherapy
41%
Survival
39%
Breast Neoplasms
36%
Peroxisome Proliferator-Activated Receptors
35%
Therapeutics
33%
Colonic Neoplasms
31%
Kidney
31%
Proteins
30%
3,3'-diindolylmethane
30%
pembrolizumab
29%
Aryl Hydrocarbon Receptors
29%
Apoptosis
28%
Hepatocellular Carcinoma
26%
Transplant Recipients
26%
Circulating Tumor DNA
26%
Estrogen Receptors
24%
Neoadjuvant Therapy
22%
Survivin
22%
Endoplasmic Reticulum Stress
21%
1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane
21%
1,1-bis(3'-indolyl)-1-(4-t-butylphenyl)methane
21%
estrophilin
20%
Colorectal Neoplasms
20%
Acute Kidney Injury
18%
Adenocarcinoma
18%
Renal Cell Carcinoma
18%
gemcitabine
18%
Carcinogenesis
17%
Vascular Endothelial Growth Factor A
17%
Vascular Endothelial Growth Factor Receptor-2
16%
Drug Therapy
16%
Organ Transplantation
16%
Pharmaceutical Preparations
16%
Genes
16%
RNA
15%
Cytoplasmic and Nuclear Receptors
15%
Down-Regulation
15%
GC Rich Sequence
15%
teleocalcin
15%
Allogeneic Cells
14%